Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:
Acorda Gains Approval for Ampyra

January 25, 2010
Acorda Therapeutics, Inc. received approval from the FDA for Ampyra (dalfampridine) to improve walking in patients with multiple sclerosis (MS).  Read More »
Chinese SFDA Approves Sinobiopharma Facility for Perindopril

January 25, 2010
Sinobiopharma’s production facility for solid dosage Perindopril has passed Chinese State Food and Drug Administration (SFDA) inspection and is now approved for production and marketing.  Read More »
J&J Withdraws EMEA Submission for Comfyde

January 22, 2010
Johnson & Johnson has withdrawn an EMEA filing for Comfyde (carisbamate), its investigational drug being developed for the adjunctive treatment of partial onset seizures with or without secondary generalization in patients aged 16 or older.  Read More »
Lumizyme BLA Receives Six-Month FDA Review

January 22, 2010
Genzyme’s BLA for Lumizyme (alglucosidase alfa) seeking approval for the therapy produced at the 4000 L scale, has received a June 17, 2010 PDUFA date from the FDA.  Read More »
Shionogi Pharma

January 22, 2010
Ray Russo has been appointed vice president, Primary Care Business Unit, at Shionogi Pharma, Inc.   Read More »
Patheon to Build Development Center in France

January 21, 2010
Patheon began construction of a new pharmaceutical development center at its existing manufacturing facility in Bourgoin-Jallieu, France.  Read More »
Merck’s HIV Drug Fails to Meet Phase III Endpoint

January 21, 2010
Merck’s HIV treatment vicriviroc did not meet the primary efficacy endpoint in two Phase III studies involving patients previously treated with other HIV medicines.  Read More »
AlphaRx, Gaia BioPharma Secure CMO

January 21, 2010
AlphaRx Inc.’s licensee, Gaia BioPharma Ltd., has signed an agreement with a CMO to manufacture GAI-122 for use in Phase I and II trials.  Read More »
NextPharma Storage Facilities Gain Full Approval

January 21, 2010
NextPharma Technologies’ expansion of its Cold Chain and Logistics (CLS) business in Austria has received full regulatory approval and has been granted a Distributors-Manufacturers License by the Austrian Federal Office for Safety in Healthcare.  Read More »
Transposagen, Taconic Enter Distribution Pact

January 21, 2010
Transposagen Biopharmaceuticals, a provider of genetically modified laboratory rats, has entered into a global marketing and distribution agreement with Taconic, an animal model and service provider, in which Taconic will market and distribute Transposage  Read More »
Wacker, Morphosys Expand Antigen Technology Pact

January 20, 2010
Wacker Chemie and MorphoSys have expanded their existing collaboration for the use of Wacker’s Esetec bacterial secretion technology.  Read More »
Ricerca Implements Watson LIMS

January 20, 2010
Ricerca Biosciences has validated and implemented Watson Laboratory Information Management System (LIMS) for its bioanalysis division.  Read More »
CDISC

January 20, 2010
Paula Brown Stafford, executive vice president, Integrated Clinical Services at Quintiles, has been appointed chair-elect of the board of directors of the Clinical Data Interchange Standards Consortium (CDISC), a global organization dedicated to the devel  Read More »
AMRI Gains Potent API Safety Certification

January 19, 2010
AMRI has received certification of its high potency research labs and GMP-manufacturing facilities in Rensselaer, NY for the safe handling of potent APIs by SafeBridge Consultants, Inc.  Read More »
Perseid Achieves Astellas Milestone

January 19, 2010
Maxygen, Inc.’s majority-owned subsidiary, Perseid Therapeutics LLC, has achieved a preclinical milestone under its collaboration with Astellas Pharma, triggering a $5 million payment to Perseid.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: